عنوان مقاله [English]
نویسندگان [English]چکیده [English]
Prostate specific antigen (PSA), a serine protease, is a highly reliable biochemical marker used for detection and management of prostate cancer. PSA in serum samples is measured by an immunoanalytical technique such as immunoradiometric assays (IRMA). In this study the preparation method and the effective factors on the efficiency and the stability of the labeled anti-PSA monoclonal antibody with I-125 as a tracer in the immunoradiometric kit (IRMA) were investigated. To perform an IRMA assay, at first, the labeled anti-PSA monoclonal antibody was formed using oxidizing agents, namely Chloramine-T and Iodogen, then the product was separated and purified by Sephadex G-25 column. After the determination of radiochemical purity, I-125 labeled antibody was used in the in-house PSA IRMA kit. The effects of the proportion antibody/I-125(17.6-53 µg/mCi), Chloramine-T/antibody (0.75 & 1.5 µg/µg) and the labeling time (15-60 s) on the efficiency and stability of the labeled antibody were studied. According to the calibration curve and concentration of control samples, Chloramine-T radioiodination procedure was optimized (Chloramine-T/antibody: 1.5 µg/µg & labeling time: 50s). The variety of the proportion antibody/I-125 was ineffective in radioiodination efficiency. The Chloramine-T radiolabeled antibody was found to be stable for 30 days when stored at 4◦C. Also radioiodination using Iodogen was studied at different Iodogen concentrations (0.1&0.2 mg/ml) and Dichlromethane volumes (0,200&400 µl). According to the obtained results, the appropriate amount of Iodogen and Dichlromethane were obtained to be 0.1mg/ml and 200µl. But Iodogen radiolabeled antibody showed poor immunoradioactivity and stability after two weeks. The results show that the Chlroamine-T procedure is more suitable than the Iodogen method, so the Chloramine-T radiolabeled antibody could be used as a tracer in IRMA system for quality control of in-house PSA kit. By studying the results of t-Test analysis, the decision criteria (sig 2-tailed= 0.993) and confidence interval (95%), it can be seen that the values are well correlated.
 M. Frydenberg, Diagnosing prostate cancer, Australian Family Physician, 36 (2007) 345-347.
 I.M. Thomson, D.P. Ankerst, Prostate specific antigen in the early detection of prostate cancer, CMAJ, 176 (2007) 1853-1858.
 S.A.R. Kort, F. Martens, H. Vanpoucke, H.L. van Duijnhoven, M.A. Blakenstein, Comparison of 6 automated assays for total and free PSA with special reference to their reactivity toward the WHO 96/670 reference preparation, Clin Chem, 52 (2006) 1568-1574.
 G. Brown, N.R. Ling, Murine monoclonal antibodies, In: Catty, D. (ed) Antibodies, a practical approach, IRL Press, Oxford, (1988).
 J.W. Feihtner, The early detection and treatment of prostate cancer, J. Urol, 152 (1994) 1682-1684.
 M.R.A. Pillai, S.D. Bhandarkar, Radioimmuno assay: principles and practice, Devi printers and binders, Thane, India (1998).
 R.H. Seevers, R.E. Counsell, Radioiodination techniques for small organic molecules, Chem. Rev., 82 (1982) 575-590.
 A. Bolton, W. Hunter, The labelling of proteins to high specific radioactivities by conjugation to a 125I-containing acylating agent, Biochem. J., 133 (1973) 529-539.
 J. Marchalonis, An enzymic method for the trace iodination of immunoglobulins and other proteins, Biochem. J., 113 (1969) 299-305.
 M. Morrison, Lactoperoxidase-catalyzed iodination as a tool for investigation of proteins, Meth. Enzymol., 70 (1980) 214-220.
 W.M. Hunter, F.C. Greenwood, Preparation of Iodine-131 labeled human growth hormone of high activity, Nature, 194 (1962) 495-496.
 P.J. Franker, J.C. Speck, Protein and cell membrane iodination with a sparingly soluble chloramide, Biochem. Biophy. Res. Common, 80 (1978) 849-857.
 W.G. Wood, Experiences using chloramine-T and 1, 3, 4, 6-Tetrachloro-3a, 6a-diphenylglycoluril (Iodogen®) for radioiodination of materials for radioimmunoassay, J. Clin. Chem. Clin. Biochem., 19 (1978) 1051-1056.
 A.P. Richardson, P.J. Mountford, A.C. Baird, E. Heyderman, T.C. Richardson, A.J. Coakley, An improved iodogen method of labelling antibodies with I-123, Nucl Med Commun., 7(5) (1986) 355-362.